Decorin evokes reversible mitochondrial depolarization in carcinoma and vascular endothelial cells

Decorin, a small leucine-rich proteoglycan with multiple biological functions, is known to evoke autophagy and mitophagy in both endothelial and cancer cells. Here, we investigated the effects of soluble decorin on mitochondrial homeostasis using live cell imaging and ex vivo angiogenic assays. We discovered that decorin triggers mitochondrial depolarization in triple -negative breast carcinoma, HeLa, and endothelial cells. This bioactivity was mediated by the protein core in a time-and dose -dependent manner and was specific for decorin insofar as biglycan, the closest homolog, failed to trigger depolarization. Mechanistically, we found that the bioactivity of decorin to promote depolarization required the MET receptor and its tyrosine kinase. Moreover, two mitochondrial interacting proteins, mitostatin and mitofusin 2, were essential for downstream decorin effects. Finally, we found that decorin relied on the canonical mitochondrial permeability transition pore to trigger tumor cell mitochondrial depolarization. Collectively, our study implicates decorin as a soluble outside-in regulator of mitochondrial dynamics.

Automated summary

This study demonstrates that Decorin triggers mitochondrial depolarization in several types of cells, including breast carcinoma, HeLa, and endothelial cells. The bioactivity of Decorin is mediated by the MET receptor and its tyrosine kinase, as well as two mitochondrial proteins, mitostatin and mitofusin 2.